Detecting HER2-positive circulating tumor cells in gastric cancer using a flow cytometry-based approach
This study introduces a noninvasive method for monitoring HER2 expression in GC, offering new insights into providing personalized treatment strategies.
Authors
- Yee Chao (ORCID: https://orcid.org/0000-0001-5578-340X)
- W. M. Lai (ORCID: https://orcid.org/0000-0001-6513-8500)
- Shian‐Ren Lin (ORCID: https://orcid.org/0000-0002-4160-2361)
- Jan‐Mou Lee (ORCID: https://orcid.org/0000-0001-6876-6465)
- Shiu-Lan Wang
- Ming‐Huang Chen (ORCID: https://orcid.org/0000-0003-3187-7393)
- Wenhui Liao (ORCID: https://orcid.org/0000-0001-8015-6918)
- Li-Yun Huang
- Po‐Lin Tseng (ORCID: https://orcid.org/0000-0003-2388-0349)
- Chia-Chun Tu (ORCID: https://orcid.org/0000-0002-3862-9950)
- Chih-Hao Fang
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Taipei City Hospital (TW)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fmed.2025.1672955
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00